Nigel H. Greig

机构：National Institutes of Health, Institute on Aging, National Institute on Aging · ORCID：0000-0002-3032-1468

发表论文 564 篇 · 总被引 33037 次 · h-index 88

代表论文

• Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial (2025 · The Lancet · 被引 139)
• Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration (2024 · Biomolecules · 被引 21)
• Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration (2025 · Journal of Biomedical Science · 被引 9)
• Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy (2025 · Annals of Neurology · 被引 7)
• 3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat (2025 · GeroScience · 被引 7)
• Zebrafish-Based Parkinson's Disease Models: Unveiling Genetic Mechanisms and Therapeutic Pathways (2025 · CNS & Neurological Disorders - Drug Targets · 被引 6)